Organigram Global Launches happly, a New U.S. Hemp-Derived THC Brand Offering Targeted Formulations for Three Mood States; Socialize, Relax, and Sleep

Executive Summary

• Organigram Global Inc. announced the U.S. launch of happly, its third hemp‑derived delta‑9 brand, featuring FAST™ nanoemulsion gummies aimed at specific mood states (socializing, relaxation, sleep).
• The line introduces three vegan gummy formats each delivering 2.5 mg THC plus functional ingredients (caffeine, L‑theanine, chamomile extract) and utilizes proprietary FAST™ nanoemulsion technology for faster onset and higher peak cannabinoid delivery.
• Initial sales will be direct‑to‑consumer via www.gethapply.com to consumers in 23 U.S. states, with retail expansion planned later in the year.

Key Details

• Brand & Positioning: happly – “The Right Amount”; targets the “mindful recreation” segment (~21 % of U.S. cannabinoid consumers), emphasizing low‑dose THC (2.5 mg) and functional benefits.
• Product Formats:
• Socialize – 2.5 mg THC + 25 mg caffeine, Blood Orange Lemonade flavor, sold in 20‑count tins.
• Relax – 2.5 mg THC + 100 mg L‑theanine, Black Cherry Lime flavor, sold in 20‑count tins.
• Sleep – 2.5 mg THC + 2.5 mg CBN + 10 mg CBD + 100 mg chamomile extract, Blueberry Lemon flavor, offered in 20‑count tins or 60‑count pouches.
• Technology: First U.S. Organigram brand to use FAST™ nanoemulsion (patent‑pending), clinically validated to deliver ~50 % faster onset and nearly double peak cannabinoid delivery versus traditional edibles.
• Distribution: Direct‑to‑consumer online sales at www.gethapply.com, shipping to 23 states (DE, GA, IL, IN, KS, ME, MN, MO, NE, NV, NH, NJ, NM, NC, OH, OK, PA, SC, SD, TN, TX, WI, WY). Retail rollout slated for later 2025.
• Strategic Rationale: Leveraging extensive consumer research indicating demand for low‑dose, functional THC products among younger adults (63 % under age 34). Aligns with Organigram’s broader U.S. hemp‑derived THC expansion following its Collective Project beverages and Fetch sodas launches earlier in the year.
• Executive Comments:
• Megan McCrae, SVP Corporate Strategy & International Growth – emphasized consumer‑driven design and the shift toward intentional, moderate THC use.
• Borna Zlamalik, SVP Innovation & International R&D – highlighted the significance of commercializing FAST™ nanoemulsion technology in the U.S. market.

Notable Quotes

• “happly is more than just a new brand, it is about redefining how hemp‑derived THC can be part of everyday life,” — Megan McCrae, SVP, Corporate Strategy & International Growth.
• “This milestone not only marks a significant step in commercializing advanced delivery systems for hemp‑derived THC but also showcases the continued success of our Product Development Collaboration with BAT,” — Borna Zlamalik, SVP of Innovation and International R&D.